Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/10/16 → 5/10/19 |
Funding
- PPD Development (Prot# IDN-6556-12 // Prot# IDN-6556-12)
- Conatus Pharmaceuticals Inc. (Prot# IDN-6556-12 // Prot# IDN-6556-12)
Prot# IDN-6556-12: A Multicenter, Randomized, Double-blind, Placebo-Controlled Trial of Emricasan (IDN-6556), an Oral Caspase Inhibitor, in Subjects with Nonalcoholic Steatohepatitis (NASH) Fibrosis
- Rinella, Mary Eugenia (PD/PI)
Project: Research project